Shares of Ingevity Corp (NYSE:NGVT) have earned an average rating of “Buy” from the eleven research firms that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $100.22.

Several research analysts have commented on NGVT shares. Zacks Investment Research raised Ingevity from a “hold” rating to a “buy” rating and set a $105.00 target price on the stock in a report on Thursday, November 22nd. Oppenheimer set a $110.00 target price on Ingevity and gave the stock a “buy” rating in a report on Monday, December 10th. Stifel Nicolaus assumed coverage on Ingevity in a research note on Monday, December 10th. They issued a “hold” rating and a $84.00 price objective on the stock. Loop Capital set a $95.00 price objective on Ingevity and gave the company a “hold” rating in a research note on Thursday, December 13th. Finally, Jefferies Financial Group set a $68.00 price objective on Ingevity and gave the company a “buy” rating in a research note on Thursday, December 20th.

In related news, EVP Katherine Pryor Burgeson sold 4,400 shares of the company’s stock in a transaction that occurred on Monday, February 25th. The stock was sold at an average price of $114.76, for a total transaction of $504,944.00. Following the transaction, the executive vice president now directly owns 8,801 shares of the company’s stock, valued at approximately $1,010,002.76. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Phillip John Platt sold 2,725 shares of the company’s stock in a transaction that occurred on Tuesday, February 26th. The stock was sold at an average price of $114.07, for a total value of $310,840.75. Following the transaction, the chief accounting officer now directly owns 1,137 shares in the company, valued at $129,697.59. The disclosure for this sale can be found here. Insiders sold a total of 25,125 shares of company stock worth $2,876,065 over the last three months. 0.18% of the stock is owned by company insiders.

Hedge funds have recently bought and sold shares of the stock. Oppenheimer Asset Management Inc. acquired a new position in Ingevity during the 4th quarter worth approximately $25,000. Signaturefd LLC raised its stake in Ingevity by 211.9% during the 3rd quarter. Signaturefd LLC now owns 1,472 shares of the company’s stock worth $150,000 after buying an additional 1,000 shares during the period. ETF Managers Group LLC raised its stake in Ingevity by 17.4% during the 4th quarter. ETF Managers Group LLC now owns 1,793 shares of the company’s stock worth $150,000 after buying an additional 266 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. acquired a new position in Ingevity during the 4th quarter worth approximately $177,000. Finally, Ibex Investors LLC acquired a new position in Ingevity during the 3rd quarter worth approximately $201,000. 92.81% of the stock is currently owned by institutional investors and hedge funds.

Shares of NGVT opened at $104.12 on Tuesday. The stock has a market cap of $4.65 billion, a price-to-earnings ratio of 25.21, a P/E/G ratio of 1.91 and a beta of 1.65. Ingevity has a 12 month low of $70.71 and a 12 month high of $120.41. The company has a debt-to-equity ratio of 2.19, a quick ratio of 1.26 and a current ratio of 2.31.

Ingevity (NYSE:NGVT) last announced its earnings results on Wednesday, February 13th. The company reported $1.07 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.29. The firm had revenue of $278.60 million for the quarter, compared to the consensus estimate of $265.60 million. Ingevity had a return on equity of 53.18% and a net margin of 14.92%. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 EPS. On average, equities research analysts forecast that Ingevity will post 4.87 EPS for the current year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats.

Recommended Story: Options Trading – What is a Straddle?

Analyst Recommendations for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.